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The mechanisms by which Mycobacterium tubercu-
losis (Mtb) maintainsmetabolic equilibrium to survive
during infection and upon exposure to antimycobac-
terial drugs are poorly characterized. Ergothioneine
(EGT) and mycothiol (MSH) are the major redox
buffers present in Mtb, but the contribution of EGT
toMtb redox homeostasis and virulence remains un-
known. We report that Mtb WhiB3, a 4Fe-4S redox
sensor protein, regulates EGT production and main-
tains bioenergetic homeostasis. We show that cen-
tral carbon metabolism and lipid precursors regulate
EGT production and that EGT modulates drug sensi-
tivity. Notably, EGT and MSH are both essential for
redox and bioenergetic homeostasis. Transcrip-
tomic analyses of EGT and MSH mutants indicate
overlapping but distinct functions of EGT and MSH.
Last, we show that EGT is critical for Mtb survival in
both macrophages and mice. This study has uncov-
ered a dynamic balance betweenMtb redox and bio-
energetic homeostasis, which critically influences
Mtb drug susceptibility and pathogenicity.
INTRODUCTION
Tuberculosis (TB) is the second most common cause of death
from an infectious agent after HIV. This is largely due to the ability
of Mycobacterium tuberculosis (Mtb) to remain in a dormant,
drug-tolerant state for decades in humans before emerging to
cause active disease in10% of those infected.Mtb is exposed
to environments with a wide range of available carbon sources,
reactive oxygen intermediates (ROIs), and reactive nitrogen in-
termediates (RNIs) inside the host that may cause cell death.
Therefore, it is strongly anticipated that the ability ofMtb tomain-572 Cell Reports 14, 572–585, January 26, 2016 ª2016 The Authorstain redox balance and metabolic homeostasis is critical to its
pathogenicity and virulence (Kumar et al., 2011). In addition,
some front-line TB drugs such as isoniazid are prodrugs that
require bioreduction by Mtb for anti-mycobacterial activity (Lei
et al., 2000). Thus, a fundamental challenge to global TB control
is to understand the mechanisms by which Mtb adapts to
diverse carbon sources and redox environments encountered
in the host.
Mtb produces mycothiol (MSH; Figure 1A), which acts as a
major redox couple to protect against various redox stressors
and anti-TB drugs (Buchmeier et al., 2003; Rawat et al., 2007).
Mtb also produces a second thiol couple, ergothioneine (EGT;
Figure 1B), a sulfur-containing histidine derivative with potent
antioxidant properties (Genghof, 1970; Hand and Honek,
2005). However, despite considerable effort, roles for EGT in
Mtb and its potential involvement in redox homeostasis and
pathogenesis remain unknown. Recently, we have shown that
EGT levels in Mtb are modulated by protein phosphorylation
during transition into late states of growth (Richard-Greenblatt
et al., 2015), yet it is still unclear why mycobacteria produce
both EGT and MSH to maintain redox homeostasis.
Redox balance is essential for energy metabolism, including
glycolysis, the tricarboxylic acid (TCA) cycle, and oxidative
phosphorylation (OXPHOS). Despite this strong interdepen-
dence between redox homeostasis and energy metabolism,
very few tools are available to investigate mycobacterial bio-
energetics in real time and in a noninvasive manner. Since
cellular respiration involves a complex interplay of biological
factors, including the availability, nature, and concentration of
oxidizable substrates as well as energy demand, methods for
detecting such bioenergetic perturbations in Mtb will be of
great value.
We previously demonstrated that WhiB3, an Mtb 4Fe-4S
cluster redox sensor and virulence protein, maintains intracel-
lular redox homeostasis of the mycobacterial cell to provide
metabolic and cellular integrity (Singh et al., 2007, 2009; Steyn
et al., 2002). In this study, we examined how WhiB3 controls
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Figure 1. Metabolomic Analysis of DwhiB3 Demonstrates Increased Levels of EGT
(A and B) Chemical structures of (A) MSH and (B) EGT.
(C) Principal-component analysis shows that WTMtb, DwhiB3, and DwhiB3:comp strains can be distinguished based on their overall metabolomic profiles. For
metabolomic analysis, each strain was independently examined at least twice in triplicate.
(D) Volcano plot of metabolites in WTMtb and DwhiB3 plotted as fold change versus significance. The green lines demarcate metabolites with a greater than 2-fold
changeonthexaxisandacorrectedpvalue<0.05 (289/3,327molecules).Metaboliteswith less thana2-foldchangeand/orp>0.05areshown ingray.SeealsoTable1.
(E) Independent validation of EGT production inWTMtb,DwhiB3, andDwhiB3:comp based on LC-MS analysis after growth onmedium containing 5mMacetate.
Error bars denote SEM.
(F) Untargeted metabolite profiling assessed by MetPa enrichment analysis, based on changes in the relative abundance of metabolites (see also Figure S1 and
Table S1), indicate that WhiB3 has a profound effect on Mtb metabolism, especially carbon catabolism, bioenergetic metabolism, amino acid metabolism, the
pentose phosphate pathway (PPP), and glycolysis.
(legend continued on next page)
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Table 1. MetPa Analysis of Pathways Altered in DwhiB3
Compared to WT Mtb
KEGG Pathway Name
Metabolites
p Value ImpactTotal Hits
Arginine and proline metabolism 41 12 0.000189 0.19
Glycine, serine, and threonine
metabolism
32 10 0.000378 0.60
Lysine biosynthesis 13 6 0.000588 0.38
Pantothenate and CoA
biosynthesis
23 8 0.000681 0.41
Butanoate metabolism 18 7 0.000699 0.32
Valine, leucine, and isoleucine
biosynthesis
26 8 0.00171 0.24
Cysteine and methionine
metabolism
34 9 0.00282 0.34redox and bioenergetic homeostasis in Mtb to moderate viru-
lence. We used a combination of metabolomic, bioenergetic,
and transcriptomic approaches and established links between
WhiB3 and bioenergetic homeostasis and EGT, a major redox
buffer. We characterized the genetic architecture of the EGT
biosynthesis operon in Mtb and assessed the contribution of
EGT in protection against oxidative stress, in antimycobacterial
drug susceptibility, and in bioenergetic homeostasis. Further,
we examined a link between Mtb central carbon catabolism
and EGT production and the relationship between EGT and
MSH biosynthesis. Using genome-wide expression analysis of
genetically defined mutants of MSH and EGT biosynthesis, we
identified differentially regulated genes common to all Mtb mu-
tants. Finally, using macrophages and a mouse model of infec-
tion, we establish that maintaining redox balance and bioener-
getic homeostasis is essential for Mtb virulence.Alanine, aspartate, and
glutamine metabolism
18 6 0.0043 0.66
Citrate cycle (TCA cycle) 20 5 0.0327 0.11
Metabolic Pathway Analysis (MetPa) combines pathway enrichment
analysis with pathway topology analysis to identify the most relevant
pathways under the specified conditions. MetPa uses the KEGG meta-
bolic pathways as the backend knowledge base and integrates univariate
analysis, over-representation analysis, Global Test, GlobalAncova, and
network topology analysis into pathway analysis. The total/maximum
importance of each pathway = 1; pathway impact value = cumulative
% from the matched metabolic nodes. Pathways with the most signifi-
cant change (p% 0.05) are listed. KEGG, Kyoto Encyclopedia of Genes
and Genomes; TCA, tricarboxylic acid. See also Table S1.RESULTS
WhiB3 Regulates EGT Production in Mtb
Since Mtb WhiB3 is an intracellular redox sensor (Singh et al.,
2009), we sought to identify redox-responsive metabolites regu-
lated by WhiB3. We analyzed the metabolomes ofMtb (H37Rv),
DwhiB3 and the corresponding whiB3-complemented strain
(DwhiB3:comp), under rigorously controlled conditions (de
Carvalho et al., 2010). Metabolites were separated by high-per-
formance liquid chromatography (HPLC) and detected by
electrospray ionization coupled to mass time-of-flight mass
spectrometry (liquid chromatography-tandem mass spectrom-
etry [LC-MS/MS]) as previously described (Rhee et al., 2011).
Among the statistically significant differences detected (Figures
1C, 1D, and S1) was the increased production of EGT inDwhiB3.
Independent validation showed a 7.3-fold increase in EGT levels
in DwhiB3 (Figure 1E), and complementation of whiB3 restored
the EGT content to near wild-type levels (Figure 1E).
Next, we performed Metabolic Pathway Analysis (MetPa),
which combines pathway enrichment analysis with pathway to-
pology, to detectmetabolic differencesbetweenMtbandDwhiB3
(Everts et al., 2014; Nandakumar et al., 2014). This analysis high-
lighted changes in the abundance of metabolites of biochemical
pathways inDwhiB3, including glycolysis, the pentose phosphate
pathway, the TCA cycle, and several amino acid biosynthesis
pathways (Figure 1F; Tables 1 and S1). The pyruvate node is of
particular significance as it is a key intermediate of many amino
acid metabolism pathways, glycolysis, and the TCA cycle (Fig-
ure 1G; Table S1).
Overall, these metabolomic data demonstrate that WhiB3
modulates the production of EGT. Further analyses revealed
that WhiB3 also modulates the production of several amino
acids, which act as anaplerotic and cataplerotic substrates
and converge on glycolysis and the TCA cycle to affect energy
metabolism (Figure 1G).(G) EGT is linked to the metabolism of histidine (His) as it is derived from hercynin
Glycolysis and the TCA cycle both feed into the electron transport chain to regula
which maintain bioenergetic homeostasis. Amino acids acting as anaplerotic and
See also Figure S1 and Table S1.
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Next, we optimized extracellular flux analysis previously applied
only to eukaryotic cells, for the study ofMtb. In this method, fluo-
rescence sensors measure dissolved extracellular oxygen and
proton concentration in real time in a microtransient chamber
formed when the probes are in the measurement position. Inhib-
itors, modulators, or substrates can be added during the run
through delivery ports in the cartridge. This technology allowed
us to accurately measure the oxygen consumption rate (OCR)
and the extracellular acidification rate (ECAR) of Mtb cells in
real time in a noninvasive manner (Figure 2A). The OCR and
ECAR are direct and highly sensitive measures of cellular meta-
bolic activity (Ferrick et al., 2008). ECAR gives a measure of H+
extrusion associated with carbon catabolism via glycolysis and
the TCA cycle, whereas OCR is indicative of cellular respiration
due to OXPHOS. The cell energy phenotype can be deduced
from a phenogram (plotting of OCR versus ECAR) that illustrates
metabolic shifts between substrate oxidation and glycolysis. We
used pyruvate, identified as a key glycolytic intermediate (Fig-
ure 1G; Table S1), as the sole carbon source in extracellular
flux analyzer (XF) bioenergetic assays. We used carbonyl cya-
nidem-chlorophenylhydrazone (CCCP), amembrane uncoupler,
to examine the capacity of WhiB3 to maintain bioenergetice (Her), and MSH biosynthesis is regulated by NADPH produced by the PPP.
te the electrical (Dc) and concentration (DpH) gradients across the membrane,
cataplerotic substrates are boxed.
AB C
Figure 2. Extracellular Flux Analysis Demonstrates the Bioenergetic Deficiency of DwhiB3
(A) Diagram of the probe of an XF96 cartridge and a well of the cell culture microplate. During the assay, ECAR is measured as an indication of H+ production from
carbon catabolism and OCR as an indication of OXPHOS.
(B) OCR profiles of WTMtb H37Rv (blue), DwhiB3 (red), and DwhiB3:comp (green) in the presence of pyruvate (50 mM, M1) and after addition of two aliquots of
CCCP to a final concentration of 1 mM and 8 mM (M7) indicated by the vertical dotted lines.
(C) Phenogram of all three strains at M1 (after pyruvate addition) and M7 (after the second CCCP addition) demonstrating increased OCR and ECAR of WTMtb
H37Rv and DwhiB3:comp after CCCP addition in contrast to the inability of DwhiB3 to respond to the uncoupling stress.homeostasis upon uncoupling of OXPHOS fromATP production.
In the presence of pyruvate, DwhiB3 had a significantly lower
OCR than WT and DwhiB3:comp (Figure 2B). After addition of
CCCP (8 mM; M7), both the WT and DwhiB3:comp strains re-
sponded to the uncoupling stress by increasing OCR (Figure 2B).
TheOCR and ECARdata from these experiments were plotted to
generate a phenogram, which provides a visualization of the
overall metabolic profiles of the different strains (Figure 2C).
Our data show that DwhiB3, in contrast to WT Mtb, did not
respond with an increase in OCR or ECAR to re-establish
membrane potential (M7, Figure 2C), indicating that DwhiB3 is
bioenergetically deficient.
In sum, we optimized extracellular flux analysis for the study of
Mtb bioenergetics. Adapting this technology toward Mtb has
broad implications for studying bioenergetics of microbial
pathogens in general. The results demonstrate that in the
absence of WhiB3, Mtb cannot respire efficiently when the
glycolytic intermediate pyruvate is the sole carbon source. This
suggests that the absence ofWhiB3 leads to dysfunctional respi-
ration and confirms its involvement in maintaining bioenergetic
homeostasis.CEGT Detection Using TLC
The study of EGT biosynthesis in bacteria has been hampered by
the fact that EGT quenches the fluorescence of bimane deriva-
tives, thereby making routine detection of EGT by HPLC analysis
difficult. We therefore developed a rapid thin-layer chromatog-
raphy (TLC)-based radioactive labeling assay and showed that
pure EGT has an Rf value of 0.46 (Figure S2A). TLC analysis
of concentratedM. smegmatis (Msm) andMtb extracts revealed
bandswith Rf values consistent with that of pure EGT (Figures 3A
and S2A). LC-MS/MS analysis of these bands and an EGT stan-
dard revealed virtually identical retention times and confirmed
them to be EGT (Figures 3B, 3C, and S2B). An earlier study in
Claviceps purpurea showed that [2-14C]-acetate could be used
to label EGT (Heath and Wildy, 1956). However, we could not
detect labeled EGT after TLC analysis of extracts from Msm
cultured in the presence of [2-14C]-acetate even though UV
exposure revealed a band at the same position as pure EGT,
indicating that EGT was present (Figure 3D). However, by using
[35S]-Cys as a precursor, we observed a labeled spot after
TLC analysis with the same Rf value as the EGT identified by
LC-MS/MS analysis (Figure 3E).ell Reports 14, 572–585, January 26, 2016 ª2016 The Authors 575
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Figure 3. Detection of EGT by TLC Analysis and WhiB3 Regulation of EGT in Response to Carbon Catabolism
(A) TLC analysis of Mtb and M. smegmatis (Msm) extracts followed by application of 0.2% ethanolic Gibb’s reagent. EGT appears as a brick-red spot with Rf
values near 0.46.
(B) This band on the TLC plate was extracted and analyzed by LC-MS/MRM to confirm its identity as EGT. The main elution peak at a retention time of 1.4201 min
represents EGT.
(C) LC-MS/MRM analysis of an EGT standard with a retention time of 1.4397 min confirmed the band in (B) is EGT.
(D)Mtb cells were grown in the presence of 5 or 10 mCi of [2-14C]-acetate followed by extraction in water and TLC analysis using 50,000 counts. Exposure of the
TLC plate to a phosphor storage screen and viewing by phosphoimaging (left) or a UV lamp at 256 nm revealed the EGT band (green image; EGT bands; arrow).
(E) EGT was detected in extracts of 35S-cysteine-fed cultures followed by TLC and autoradiography and was confirmed by LC-MS/MS.
(F) LC-MS/MS quantitation of EGT in Mtb, DwhiB3, and DwhiB3:comp strains that were cultured in glucose, various fatty acids, or the breakdown products of
b-oxidation as the sole carbon sources. Error bars represent SEM, n = 3, and *p < 0.05.
See also Figure S2.Altogether, we have developed a simple radioactive TLC-
based assay that facilitates the rapid, routine examination of
EGT in mycobacteria and potentially other EGT-producing bac-
teria. Further, this method revealed differences in the biosyn-
thetic pathways of either EGT or EGT precursors between fungi
and mycobacteria.
WhiB3-Mediated Regulation of EGT Production Is
Dependent on Central Carbon Metabolism
Since WhiB3 initiates the metabolic switchover to the preferred
in vivo carbon source (fatty acids) and integrates redox signals
with core intermediary metabolism (Singh et al., 2007, 2009),
we sought to establish whether the type of carbon source influ-
ences WhiB3-mediated regulation of EGT production. LC-MS/
MS was used to quantify intracellular EGT in Mtb, DwhiB3, and
DwhiB3:comp grown in physiologically relevant concentrations
(50 mM [Lee et al., 2013]) of carbon sources, including glucose,
lipids, and lipid precursors. As shown in Figure 3F, DwhiB3
had significantly increased levels of EGT compared to WT or
DwhiB3:comp when grown in glucose, acetate, cholesterol,
behenate, stearate, myristate, or palmitate and no difference
when grown in propionate. EGT levels in WT Mtb ranged from
40 to over 300 ng/108 cells with higher (>200 ng/108 cells) levels
occurring in cells grown inmyristate (C-14), palmitate (C-16), and576 Cell Reports 14, 572–585, January 26, 2016 ª2016 The Authorsstearate (C-18).DwhiB3 grown in the sameC-14, C-16, andC-18
fatty acids produced even higher levels of EGT (R400 ng/108
cells). We observed EGT levels < 120 ng/108 cells in WT Mtb
grown on glucose, propionate (C-3), acetate (C-2), behenate
(C-22), and cholesterol (C-27).DwhiB3 grown in these substrates
had similarly lower EGT levels albeit significantly higher than the
WT, with the exception of glucose, where levels were > 250 ng
EGT/108 cells. In sum, these data demonstrate that WhiB3 reg-
ulates EGT production in response to catabolism of a diverse
set of fatty acid precursors and cholesterol.
The Mtb EGT Operon
In vitro reconstitution studies using protein preparations of Erwi-
nia tasmaniensis and Msm (Seebeck, 2010), as well as a recent
genetic study in Msm (Sao Emani et al., 2013), have provided
biochemical and genetic evidence for EGT production in Msm.
Analysis of the Mtb genome led us to predict that locus
Rv3704c–Rv3700c constitutes the EGT biosynthetic operon.
Figure 4C shows the genetic organization and biochemical
pathway involved in EGT production and the link between EGT
and MSH biosynthesis in Mtb. Examination of EGT production
in Mtb CDC1551 and corresponding transposon mutants that
disrupt egtA or egtD (hereafter referred to as egtA:Tn and
egtD:Tn) revealed thatMtb egtA:Tn and egtD:Tn do not produce
A B
C
D E F
G
H
(legend on next page)
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EGT (Figure 4A). Production of EGT in egtA:Tn was successfully
complemented with the addition of the complete egt gene clus-
ter (Rv3704c–Rv3700c, egtA:TnC) and partially complemented
in egtD:Tn with the addition of egtD (egtD:TnC; Figure 4B). The
arrangement of the egt genes, with egtA/egtB and egtC/egtD
having overlapping stop and start codons (50-GTGA-30 and
50-ATGA -30, respectively), suggested that theymay be operonic.
RT-PCR analysis established that egtA through egtD are indeed
operonic, while egtE is not (Figure S3). In sum, we have
confirmed the genetic components and operonic organization
(Rv3704c–Rv3700c) responsible for EGT biosynthesis in Mtb.
EGT and Mycobacterial Redox Balance
Next, to examine the biological significance of EGT, and whether
EGT andMSH are linked metabolically, we measured EGT levels
in Mtb defective in MSH production. We noticed substantially
increased EGT levels in DmshA compared to WT (Figure 4D).
HPLC analyses of reduced MSH (2MSH) and oxidized (disulfide)
MSH (MSSM) levels inMtbCDC1551, egtA:Tn, and egtD:Tn indi-
cated that the MSH/MSSM ratio does not differ in the Mtb EGT
mutants (Figure 4E).
We then examined the endogenous reactive oxygen species
(ROS) levels inMtb strains defective in EGT or MSH production.
Flow cytometry analysis of WT, egtA:Tn, and DmshA following
exposure to the ROS-responsive dye CellROX Green revealed
that egtA and mshA mutants have a significantly increased per-
centage of cells that produce ROS under normal growth condi-
tions (Figure 4F). Compared to WT, egtA:Tn had 25-fold and
DmshA had 8-fold more ROS-producing cells. Further, the eg-
tA:Tn strain had 3-fold more ROS-producing cells compared to
DmshA. The increasedEGT levels observed inDmshA (Figure 4D)
likely mitigate the endogenous ROS in this mutant. We conclude
that while a lack of MSH substantially increases levels of EGT,
loss of EGT does not lead to a corresponding increase in
MSH/MSSM, which may be the cause of increased endogenous
ROS levels observed in the egtA mutant. These data establish a
physiological link between MSH and EGT production inMtb and
confirm their role in controlling endogenous ROS.
Role of EGT in Protection against Oxidative Stress
The role of MSH in protecting mycobacteria from oxidative
stress is well documented (Buchmeier et al., 2003; Miller et al.,
2007). However, we know little about the role of EGT inFigure 4. Genetic Characterization of the EGT Biosynthetic Operon in
(A) TLC and autoradiographic analyses of 35S-cysteine-fed egtA:Tn, egtD:Tn, and
egtD abrogates EGT production.
(B) Genetically complemented strains egtA:TnC and egtD:TnC produce EGT. Co
(C) Model depicts a putative link between the MSH and EGT pathways via Acety
(D) TLC and autoradiographic analyses of 35S-cysteine-fed Mtb CDC1551 and it
duction in the mutant lacking MSH.
(E) HPLC measurement of reduced (MSH) and oxidized (MSSM) mycothiol. MSH
(F) Flow-cytometric measurement of endogenous ROSwith CellROXGreen dye in
producing cells relative to WT (***p < 0.001, **p < 0.005, and *p < 0.05, respectiv
(G) EGT protectsMtb against oxidative stress. Following exposure to H2O2, PQT,
was determined relative to untreated (UT) cells for each strain. Each column repres
(H) Lack of EGT increases susceptibility ofMtb to RIF, INH, BDQ, and CFZ. Graph
egtA:Tn, egtD:Tn, and DmshA relative to the WT strain (see also Table S2). Com
resents the mean ± SD (n = 4, *p < 0.05, **p < 0.01, and ***p < 0.001) compared
See also Figure S3 and Table S2.
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of EGT to protect Mtb under various conditions of oxidative
stress. We observed that both egtA:Tn and egtD:Tn were signif-
icantly more sensitive than WT upon exposure to hydrogen
peroxide (H2O2), paraquat (PQT), menadione (MND), and cu-
mene hydroperoxide (CHP) (Figure 4G). Survival of egtA:Tn
and egtD:Tn was reduced most significantly by CHP and MND.
Compared to egtA:Tn, viability of egtD:Tn was significantly
decreased following exposure to H2O2 or PQT (Figure 4G). We
noted that egtA:Tn is susceptible only at the higher concentra-
tion of PQT. Complementation of the mutants restored protec-
tion against the oxidants, and viability was similar to that of WT
Mtb. Altogether, these findings provide evidence that EGT pro-
tects Mtb from a diverse set of oxidative stressors.
EGT and Antimycobacterial Drug Susceptibility
The redox status and metabolic state ofMtb can affect its sensi-
tivity to anti-TB drugs (Baek et al., 2011; Kumar et al., 2011; Nan-
dakumar et al., 2014). Here, we tested the hypothesis that lack
of EGT in Mtb modulates susceptibility to front-line anti-TB
drugs. To address this, we used a colony-forming unit (CFU)-
based viability assay to determine drug susceptibilities. We
observed that, compared toWTMtb, the minimal inhibitory con-
centration (MIC) of rifampicin (RIF), isoniazid (INH), bedaquiline
(BDQ), and clofazimine (CFZ) was significantly reduced for the
egtA:Tn, egtD:Tn, and DmshA strains (Table S2). At MIC values
obtained for WT Mtb, the percentage survival of egtA:Tn,
egtD:Tn, and DmshA was < 40% and < 25% of WT Mtb in the
presence of RIF and INH, respectively (Figure 4H). Similarly,
against CFZ and the recently developed drug BDQ, survival of
egtA:Tn and egtD:Tn strains was reduced to < 70% and <
50% of WT Mtb, respectively. Genetic complementation of the
egtA/egtD and mshA mutants reduced drug susceptibility to
near wild-type levels. As shown in Figure 4H, drug susceptibil-
ities of the egt mutants against INH and RIF were comparable
to that of DmshA (MIC = 0.015 and 0.006 mg/ml, respectively).
Of note, DmshA was significantly more susceptible to BDQ
and CFZ compared to WT Mtb and the egtA/D mutants,
revealing a greater role for MSH in protecting against these
drugs. These data demonstrate that the lack of EGT results in
increased susceptibility to anti-TB drugs and indicate that
EGT and MSH are not fully redundant and have overlapping
but distinct functional roles in Mtb physiology.Mtb
the correspondingWT strain (MtbCDC1551) indicate that disruption of egtA or
mplementation in egtD:TnC appeared to be partial.
l-Cys and Cys (indicated by dotted arrows).
s corresponding DmshA strain (duplicate samples) show increased EGT pro-
/MSSM ratio is presented as the mean ± SD of three independent cultures.
Mtb revealed that the egtA:Tn and DmshAmutant had significantly more ROS-
ely) or corresponding complemented strains.
MND, and CHP, cells were plated and CFUs enumerated. Percentage survival
ents themean ±SD (n = 4, *p < 0.05, and **p < 0.01) compared to theWT strain.
s show, at MIC values obtained for WTMtb, the percentage survival (CFUs) of
plementation restored drug sensitivities to near WT levels. Each column rep-
to WT strain.
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Figure 5. MSH and EGT Are Critical for Maintaining Bioenergetic Homeostasis in Mtb
(A–F) OCR profiles of WT Mtb (blue), DmshA (red), and DmshA:comp (green) (A and D). Also shown are corresponding ECAR measurements (B and E) and
phenograms (C and F) of the three strains at M1 and M7, with 50 mM glucose (A–C) or 50 mM acetate (D–F) as carbon sources.
(G–L) OCR profiles of WTMtb (blue), egtA:Tn (red), and egtA:TnC (green) (G and J); corresponding ECAR measurements (H and K). Phenograms (I and L) of the
three strains are shown at M1 and M7, with 50 mM glucose (G–I) or 50 mM acetate (J–L) as a carbon source. Error bars represent SEM; nR 16.
CCCP to a final concentration of 1 mM and 8 mM is indicated by vertical dotted lines in (A), (D), (G), and (J).EGT andMSH Are Critical for Bioenergetic Homeostasis
inMtb
Since reduction/oxidation reactions (redox) and energy meta-
bolism are intricately linked, we tested the hypothesis that redox
buffers MSH and EGT are essential for maintaining bioenergetic
homeostasis. Extracellular flux analysis showed alterations in the
bioenergetic profiles (OCR and ECAR) ofmshA and egtAmutant
strains when using glucose or acetate as the sole carbon source.
Genetic complementation of these mutants restored the bioener-Cgetic phenotype comparable toWT, suggesting that lack of either
EGT or MSH alters respiration in Mtb (Figures 5A–5L). The OCR
(M1) of egtA:Tn and DmshA grown in acetate was higher than
that of their respective WT strains (Figures 5D and 5J). However,
addition of CCCP (M7) resulted in an increase in OCR (Figures
5A, 5D, and 5J) and ECAR (Figures 5B, 5E, and 5K) of egtA and
mshA mutants that was significantly greater than that of WT and
complemented strains, with the exception of the egtA comple-
mented strain in glucose (M7, Figures 5G and 5H). This is alsoell Reports 14, 572–585, January 26, 2016 ª2016 The Authors 579
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Figure 6. Whole-Genome Transcriptional
Profiling of WT Mtb, egtA:Tn, egtD:Tn, and
DmshA
(A) Illustration of the overlap of the transcriptomic
responseofMtbmutants defective inEGTandMSH
production (Venndiagram).Alsoshownareselected
subsets of differentially regulated genes in each
strain classified according to function. Green: up-
regulation, red: downregulation. See Figures S4–S6
for a detailed list of differentially regulated genes.
(B) Microarray analysis of egtA:Tn, egtD:Tn, and
DmshA grown under normal conditions identified
a common set of 25 genes, 22 of which were
downregulated. Genes displaying at least 1.75-
fold variation in expression, with a q value of 1%,
were considered to be differentially regulated. The
q value is the equivalent of the p value after mul-
tiple-testing correction (see Supplemental Exper-
imental Procedures).
(C) Quantitative real-time PCR analysis of a subset
(10 of 25) of genes under normal growth condi-
tions to validate microarray profiles. Expression of
sigA was used as an internal control, and gene
expression values were normalized to WT (Man-
ganelli et al., 1999).
(D) Fold change in gene expression upon expo-
sure to oxidative stress (CHP) relative to expres-
sion in unexposed cells. Expression of sigB
(Rv2710) and sigH (Rv3223c) was used as a pos-
itive control to evaluate oxidative stress response.
*Sole gene (Rv2136c) unaffected by any uncou-
pler, respiratory inhibitor, membrane potential, or
DpH modulator (Boshoff et al., 2004).
See also Figures S4–S6 and Tables S3 and S4.highlighted in the phenograms in Figures 5C, 5F, 5I, and 5L, where
clear shifts occur from lowOCRandECAR in themutants atM1 to
higher OCR and ECAR than the WT and complemented strains at
M7. Importantly, the substantially different bioenergetic profiles580 Cell Reports 14, 572–585, January 26, 2016 ª2016 The Authorsupon addition of an uncoupler suggest
electron transport chain dysfunction in
the mutants resulting in greater OCR and
ECAR in order to reestablish their mem-
brane potentials. The unexpectedly high
OCR observed in the egtA complemented
strain at the higher concentration of CCCP
(M7, Figure 5G) could be due to aberrant
behavior of constitutive hsp60 promoter
in theepisomalplasmidof thecomplement
andhasbeenobservedpreviously inmeta-
bolic studies (Hartmanetal., 2014). In sum,
our data support the paradigm that alter-
ations in redox status canmodulate bioen-
ergetic functions inMtb cells.
Identification of Differentially
Regulated Genes in EGT- and MSH-
Deficient Mtb
Genes that contribute toward maintaining
endogenous redox balance inMtb are not
well defined. To identify this core subsetof genes, we carried out whole-genome transcriptomic profiling
and compared the gene expression profiles of Mtb strains defi-
cient in egtA (Figure S4), egtD (Figure S5), andmshA (Figure S6).
Compared to WT Mtb, 139 genes are differentially expressed in
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Figure 7. Survival and Pathogenicity of Mtb egt Mutants in Macrophages and Mice
(A) Survival of WT Mtb, egtA:Tn, egtD:Tn, and the corresponding complemented strains following macrophage infection. At the indicated time points, infected
cells were lysed (n = 3) and lysates plated to enumerate CFUs. Each data point represents the mean ± SEM (*p = 0.0142, and **p = 0.0093).
(B–E) Mice were infected with WTMtb, egtA:Tn, egtD:Tn, or the complemented strains. At 5 weeks postinfection, lungs were processed, and bacillary burden (B
and C) was determined. Columns represent the mean, and error bars represent the SD of the mean of 4–7 mice per group (**p < 0.01). Corresponding EGT
concentrations (D and E) were determined. Horizontal lines show the mean, and error bars represent the SD of the mean of 4–7 mice per group.
(F) Gross pathology of mouse lungs infected with WT Mtb, egtA:Tn, and egtA:TnC.
(G) H&E staining of lung tissue from infected mice (103 magnification). Scale bar, 100 mm.DmshA, and 68 and 74 genes in the egtA and egtD mutant
strains, respectively (Figure 6A). Notably, a common set of 25
genes was differentially regulated across all three strains (Fig-
ure 6B). The changes in gene expression observed in the micro-
array analysis were validated independently in egtA:Tn, egtD:Tn,
and DmshA by quantitative real-time PCR analysis on a select
subset of 10 genes (Figure 6C). Quantitative real-time PCR anal-
ysis of egtA:TnC, egtD:TnC, and DmshA:comp yielded gene
expression values comparable to WT (Table S3).
Importantly, 24 of the 25 differentially regulated genes shared
by the EGT- and MSH-deficient strains are differentially
regulated by inhibitors of respiration (KCN, thioridazine, and
2,4-dinitrophenol), uncouplers (CCCP and N,N0-dicyclohexyl-
carbodiimide), or compounds that target an energized mem-
brane (valinomycin) or DpH (nigericin) (Boshoff et al., 2004).
Further, exposure of WT and all three mutant strains to oxida-
tive stress (CHP) resulted in substantially increased expression
of the same subset of 10 genes used in the microarray valida-
tion (Figure 6D). This observation underscores the importance
of this core set of genes in redox regulation in Mtb in the
absence of EGT and MSH under conditions of increased oxida-
tive stress.
These data demonstrate that a lack of EGT or MSH results in
differential expression of genes involved in nucleotide and sulfur
metabolism, secretion, toxin/anti-toxins, lipid metabolism, and
cytochrome biogenesis, likely as a compensatory response to
the loss of redox couples. The regulation of trx genes by MSH,Cbut not by EGT, is possibly an indicator of distinct chemical
and functional requirements of mycobacterial redox buffers.
EGT Biosynthesis by Mtb Is Required for Survival in
Macrophages and Mice
We next examined the role of EGT in intracellular Mtb survival
and virulence. We observed significantly reduced survival of
egtA:Tn and egtD:Tn in RAW264.7 macrophages at 5 days
post-infection compared to WTMtb (Figure 7A). Complementa-
tion of the egtA/egtD mutants restored intracellular survival to
near WT levels. To determine the role of EGT in Mtb pathoge-
nicity, mice were infected with WT, egtD:Tn, egtA:Tn, or the
complemented strains in two independent experiments. We
observed significantly reduced bacillary burdens in the lungs of
mice infected with egtD:Tn or egtA:Tn compared to mice in-
fected with WT Mtb. Complementation of egtD:Tn and egtA:Tn
successfully restored bacillary load to WT levels. The egtD:Tn
showed 4-fold decrease in lung bacillary burden, whereas
the egtA:Tn showed a 4-log10 reduction (Figures 7B and 7C).
Multiple lesions were observed in the lungs of mice infected
with WT and egtA:TnC strains compared to lungs of mice in-
fected with egtA:Tn (Figure 7F). Histopathological analysis of
lung sections from mice infected with WT Mtb, egtA:TnC, and
egtD:TnC strains revealed large areas of alveolar consolidation
due to lymphocyte-rich granulomatous infiltration (Figure 7G).
In addition, multinucleated giant cells were observed in and
around granulomas in the lungs of these mice. In contrast,ell Reports 14, 572–585, January 26, 2016 ª2016 The Authors 581
egtA:Tn- and egtD:Tn-infected lungs showed diffuse areas of
lymphocyte infiltration and exhibited visible alveolar spaces
with partial lung parenchyma.
Although it is known that EGT accumulates in organs that
encounter oxidative stress (Cheah and Halliwell, 2012), it is not
known whether infection by Mtb promotes accumulation of
host-derived EGT or whether Mtb itself contributes significantly
to the host EGT pool. Infection of macrophages with WT Mtb,
egtD:Tn, egtA:Tn, and complemented strains (egtD:TnC and eg-
tA:TnC) showed no significant difference in intracellular EGT
concentrations (data not shown). Also, in mice infected with
WT Mtb, egtD:Tn, egtA:Tn, or the complemented strains, we
observed no statistically significant differences in lung EGT con-
centrations (Figures 7D and 7E). Altogether, our findings suggest
thatMtb is not a significant contributor to host EGT during infec-
tion. In sum, independent disruption of two different genes within
the EGT biosynthetic pathway results in attenuation in vivo and
provides strong evidence for a role of EGT in Mtb intracellular
survival and virulence.
DISCUSSION
The aim of this study was to examine howMtbWhiB3 maintains
intracellular redox homeostasis and bioenergetics to regulate
virulence. Here, we discovered that the virulence factor WhiB3
is a regulator of bioenergetic homeostasis and controls the pro-
duction of a major redox buffer EGT in a carbon-source-depen-
dent manner to maintain redox balance. Furthermore, by suc-
cessfully adapting extracellular flux analysis technology, we
have shown that a lack of EGT or MSH significantly alters Mtb
respiratory activity, which establishes a direct link between
redox homeostasis and bioenergetic metabolism. Importantly,
we provide evidence that redox and bioenergetic homeostasis
contribute to Mtb survival in macrophages and in mice and are
critical components in drug susceptibility and sensitivity to
oxidative stress. The identification of bioenergetic deficiencies
in Mtb mutants that display no apparent phenotypic defects
when grown in vitro, but that demonstrate attenuation upon
mouse infection, points to bioenergetic homeostasis as a largely
overlooked but important factor inMtb pathogenicity. We antic-
ipate that bioenergetic homeostasis will broadly influence the
study of microbial bioenergetics and pathogenesis. In sum, we
have uncovered a dynamic balance betweenMtb redox and bio-
energetic homeostasis, which critically influencesMtb drug sus-
ceptibility and pathogenicity.
Our data indicate interdependency among central carbon
metabolism, bioenergetic homeostasis, and redox balance in
Mtb that ultimately affects drug susceptibility. This is in line
with increasing evidence of the link between bacterial meta-
bolism and drug susceptibility. For example, Lobritz et al.
(2015) demonstrated a link between cellular respiration in Es-
cherichia coli and Staphylococcus aureus and antibiotic efficacy.
Peng et al. (2015) showed that promoting TCA flux to increase
reduced nicotinamide adenine dinucleotide (NADH) and conse-
quently proton motive force in multidrug-resistant Edwardsiella
tarda restored susceptibility to kanamycin. In the case of Mtb,
metabolic profiling revealed that exposure to sub-lethal concen-
trations of INH, RIF, and streptomycin remodeled Mtb central582 Cell Reports 14, 572–585, January 26, 2016 ª2016 The Authorscarbon metabolism to enable antibiotic tolerance (Nandakumar
et al., 2014). In addition, growth-limiting stresses that redirect
Mtb carbon flux away from central carbon metabolism toward
triglyceride synthesis have been shown to diminish antibiotic
sensitivity (Baek et al., 2011). Our data affirm this link between
metabolism and antibiotic efficacy and show how the bioener-
getic and redox status of Mtb, in which EGT and MSH play a
role, affect drug susceptibility. Likewise, our study indicates
that the roles of EGT andMSH in bioenergetic and redox homeo-
stasis are essential for the resilience of Mtb against oxidative
stress, which is necessary for full virulence of Mtb.
What is the biological significance of having two redox buffers,
EGT and MSH, to protect Mtb against oxidative environments?
One explanation rests in the inherent physicochemical proper-
ties of these redox intermediaries. For example, the reduction
potential (E00) of EGT is 60 mV, and although the E00 of MSH
has not been determined, it is speculated to be in the range of
200 to320mV, as is typical for other naturally occurring thiols
(Hartman, 1990). This would enable EGT and MSH to respond
differently to a spectrum of oxido-reductive stresses to facilitate
a successful infection. This redox hierarchy may be critical to
infection as EGT has been shown to function as a scavenger of
singlet oxygen, HOd, ONOO, and HOCl radicals (Akanmu
et al., 1991). Conversely, MSH has been shown to play a protec-
tive role against dNO and CHP (alkyl peroxy radicals) (Miller
et al., 2007). Notably, EGT does not readily undergo auto-oxida-
tion and exists predominantly in the thione form rather than the
thiol form, which confers greater stability compared to other
thiols such as glutathione and MSH (Heath and Wildy, 1956).
The reduction of MSSM to MSH requires an enzymatic system
composed of a mycoredoxin, mycothiol disulfide reductase
(Mtr) and reduced nicotinamide adenine dinucleotide phosphate
(NADPH) (Patel and Blanchard, 1999), making this a highly com-
plex system compared to EGT (Cheah and Halliwell, 2012). Alto-
gether, thesephysicochemical differences likely explain theover-
lapping but distinct functions of EGT and MSH and the need
for redundancy in redox buffers in this highly evolved pathogen.
This EGT/MSH redox hierarchy is also a critical parameter in
drug susceptibility and therefore has strong clinical relevance.
For example, we found that egtA/egtD and mshA mutants are
more susceptible than WT Mtb to RIF, INH, CFZ, and the new
anti-TB drug BDQ. The egtA/egtD mutants are less sensitive
than the mshA mutant to BDQ and CFZ, both of which target
the Mtb electron transport chain (Complex V and Complex I,
respectively), thus implicating redox balance and bioenergetic
homeostasis in modulating drug susceptibility. The dissimilar-
ities in drug susceptibility phenotypes between EGT and MSH
mutants may be due to the increased levels of EGT observed
in the MSH mutant. MSH deficiency has been reported to lead
to ethionamide resistance (Vilche`ze et al., 2008) and rifampin
sensitivity (Buchmeier et al., 2003). Altogether, our results high-
light similar yet distinct roles for EGT and MSH in maintaining
redox balance and conferring drug susceptibility through
different redox or energy-mediated mechanisms.
The ability of EGT to protect against oxidative stress caused
by CHP, PQT, H2O2, and MND confirms that Mtb produces
EGT to maintain redox balance. Not all oxidative stresses are
equal, as evidenced by differences in Mtb survival in the
presence of various oxidants and the fact that a broad spectrum
of free radical reactions exists, ranging from very reducing (e.g.,
Eo
0
= 1,800 mV for CO2/CO2d) to very oxidizing (e.g., Eo0 =
2,310 mV for HOd, H+/H2O) (Buettner, 1993). The production of
both EGT and MSH to counter free radicals may partially explain
the remarkable success ofMtb as an intracellular pathogen that
persists for decades in the oxidative environment of the lung.
This work also establishes a relationship between EGT and
MSHproduction. Notably, the increased EGT levels and reduced
endogenous ROS (Figure 4F) in DmshA reveal the presence of a
compensatory mechanism wherein EGT production is increased
to mitigate endogenous oxidative stress in the absence of MSH.
Collectively, the data support that the level of EGT in the cell,
which is modulated byWhiB3 and the availability of carbon sour-
ces, serves as a buffer against redox stress such as O2
d asso-
ciated with cellular metabolic activity. The implication of this
finding is significant as carbon sources such as fatty acids or
oxidation products can modulate redox balance and thus drug
susceptibility during infection by varying EGT levels.
To understand the effects of EGT or MSH deficiency on global
gene expression inMtb, we performed transcriptomic analysis of
egtA, egtD, and mshA mutants and identified 25 differentially
regulated genes common to all three mutants. Our quantitative
real-time PCR validation underscored the accuracy of our micro-
array-based gene expression analysis. Of these 25 genes, 24 are
also modulated by respiration inhibitors, uncouplers, or com-
pounds that target an energized membrane (Boshoff et al.,
2004), implicating EGT and MSH in maintenance of bioenergetic
homeostasis. Our observations elucidate a bioenergetics-
centered model of WhiB3-mediated redox balance through EGT
and represent a paradigm for redox homeostasis in prokaryotes.
Upregulation of an operon involved in mycolic acid biosyn-
thesis (Rv2243–Rv2247) in the egtA/egtD mutants and of the
Rv1130–Rv1131 operon (encoding PrpD and PrpC in the meth-
ylcitrate cycle) in themshA and egtAmutants suggests that per-
turbations in redox balance due to lack of EGT or MSH affect
biosynthesis of different classes of lipids, which may act as sinks
for reducing equivalents (Singh et al., 2009). An important
dissimilarity between the expression profiles of egtA/egtD and
mshA mutants is that thioredoxin B (trxB1, Rv1471) and a puta-
tive thioredoxin-like gene (trx, Rv0526) are upregulated in the
mshAmutant, but not in the egtA/egtDmutants. This observation
is consistent with the requirement of MSH for thioredoxins as
reducing partners (Attarian et al., 2009). Themajority of the differ-
entially regulated genes (22 of 25) in the egtA/egtD and mshA
mutants are downregulated. Interestingly, 17 of the 22 downre-
gulated genes are upregulated (2- to 5-fold) duringMtb infection
of macrophages or under nutrient deprivation conditions in vitro
(Schnappinger et al., 2003; Betts et al., 2002). It is therefore
reasonable to posit that redox buffers EGT or MSH may also
modulate the survival ofMtb inside macrophages and thus influ-
ence the outcome of infection.
Our in vitro and in vivo infection studies clearly show that EGT-
deficient Mtb strains are attenuated and establish that EGT is
critical for the intracellular survival and virulence of Mtb (Figures
7A–7C and 7F). These results provide important insights into the
role of EGT inMtb virulence in addition to its role in drug suscep-
tibility, both of which appear to be distinct from MSH (Vilche`zeCet al., 2008). The observation that egtA and egtD contribute to
different degrees to intracellular survival is supported by the
finding that different intermediates of EGT biosynthesis may
perform antioxidant functions (Song et al., 2015) and feed into
different pathways of central carbon metabolism. Consequently,
disruption of different steps in the EGT biosynthetic pathway in
the egtA and egtD mutants likely explains the differences in
attenuation (Figures 7A–7C, 7F, and 7G).
In summary, the findings in this study reveal new mecha-
nisms by which Mtb perceives and relays metabolic signals
to maintain redox balance and bioenergetic homeostasis.
These findings establish important roles for EGT in oxidative
stress protection, drug susceptibility, and virulence in Mtb,
which are unlike MSH. The discovery of an EGT/MSH hierarchy
of redox defense mechanisms with distinct physicochemical
properties to counteract a spectrum of host-generated free
radicals and metabolites has significant implications for how
Mtb maintains redox and bioenergetic homeostasis during
persistence.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culture Conditions
All Mtb strains used in this study, unless otherwise specified, were grown at
37C in GIBCO Middlebrook (MB)7H9 (broth) or MB7H10/MB7H11 (agar) me-
dia supplemented with 0.2% glycerol, 13 ADST (albumin saline enrichment
[albumin-NaCl] with 0.05% tyloxapol) as described in Supplemental Experi-
mental Procedures.
Liquid Chromatography-Mass Spectrometry for Metabolome
Analysis
Metabolites were separated on a Cogent Diamond Hydride Type C column
and analyzed by LC-MS as described in Supplemental Experimental
Procedures.
Bioenergetic Analysis of Mtb
OCR and ECAR ofMtb strains adhered to Cell-Tak-coated XF cell culture mi-
croplates (Seahorse Bioscience) at 2 3 106 bacilli/well were measured using
an XF96 Extracellular Flux Analyzer as described in Supplemental Experi-
mental Procedures.
TLC and LC-MS/MS Analysis of EGT
Cell extracts containing radiolabeled EGT were concentrated to dryness and
resuspended in 50–100 ml of acetonitrile:methanol:50 mM ammonium acetate
(40:40:20) (AMAA). At least 30,000 cpm in amaximum of 15 ml was loaded onto
silica gel TLC plates and developed in a 3:1 methanol:water solvent system as
described in Supplemental Experimental Procedures. To validate TLC analysis
of EGT, concentrated, unlabeled Msm extract was loaded on a silica gel TLC
plate and developed as above. The suspected EGT spot was visualized under
UV light, scraped from the plate, and extracted four times with 50 ml AMAA. It
was then concentrated to dryness, resuspended in 20 ml AMAA, and examined
by an AB Sciex API-3200 Triple Quadrupole coupled to a Waters Acquity LC
system. Data were collected in the positive electrospray mode. EGT levels in
Mtb and mouse lungs were also determined using LC-MS/MS as described
in Supplemental Experimental Procedures.
Measurement of Endogenous ROS in Mtb
The percentage of ROS-producing Mtb cells was determined using CellROX
Green (Life Technologies) and flow cytometry as described in Supplemental
Experimental Procedures.
Determination of Mtb Susceptibility to Oxidants and Anti-TB Drugs
Mtb cells were cultured as described above. Mtb strains were exposed to
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Cells were plated on MB7H11 agar plates, colonies were enumerated after
4 to 5 weeks of incubation at 37C, and percentage survival was deter-
mined. Additional details are provided in Supplemental Experimental
Procedures.
Microarray Analysis
Mtb RNA was isolated and prepared as described in Supplemental Experi-
mental Procedures.
Quantitative Real-Time PCR Analysis
Total RNA was isolated from mycobacterial cells and quantitative real-time
PCR analysis was performed as described in Supplemental Experimental
Procedures.
Mtb Infection Studies and Quantitation of EGT
For in vitro infection studies, RAW264.7 macrophages were infected withMtb
strains at aMOI of ten. Mice were used as our in vivomodel of infection. Exper-
imental details are outlined in Supplemental Experimental Procedures.
Statistics
Statistical computations were performed with Prism 6.0 software (GraphPad).
Pairwise comparison was performed by Student’s t test for normally distrib-
uted data. Multiple comparisons were performed using one-way ANOVA (Tu-
key’s test) module of GraphPad.
ACCESSION NUMBERS
The accession number for the microarray data reported in this paper is EMBL
ArrayExpress: E-MTAB-4099.
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